Menu
/REGISTER
Montecito
Nixon Peabody
Chase
Bank of America
CBB
Loading...
You are here:  Home  >  Central Coast Health Watch  -  Page 88

Sansum Clinic
Latest

European regulators have good news for Amgen on cancer drugs

By   /  Friday, September 25th, 2015  /  Central Coast Health Watch, Latest news, Technology, Tri-County Public Companies  /  Comments Off on European regulators have good news for Amgen on cancer drugs

One of the world’s most expensive cancer drugs got conditional approval from European regulators on Sept. 25. Europeans granted Thousand Oaks-based Amgen conditional approval of its rare blood cancer drug Blincyto and gave a positive evaluation of Amgen’s multiple-myeloma drug Kyprolis. Blincyto is an immunotherapy that is designed to treat a rare form of leukemia Read More →

Read More →
Latest

Stockholders sue Goleta-based Sientra after shares slide

By   /  Friday, September 25th, 2015  /  Central Coast Health Watch, Latest news, Top Stories, Tri-County Public Companies  /  Comments Off on Stockholders sue Goleta-based Sientra after shares slide

Sientra’s shares nosedived more than 52 percent on Sept. 24 and several law firms around the country announced on Sept. 25 investigations into possible violations of federal securities laws. On Sept. 23, the Goleta-based breast implant manufacturer sold 3 million new shares in a public offering. The offering raised $66 million for the company before Read More →

Read More →
Latest

St. John’s Pleasant Valley Hospital in Camarillo building new tower

By   /  Thursday, September 24th, 2015  /  Central Coast Health Watch, Latest news  /  Comments Off on St. John’s Pleasant Valley Hospital in Camarillo building new tower

St. John’s Pleasant Valley Hospital in Camarillo will hold a groundbreaking ceremony at 3:30 p.m. Sept. 24 for a three-story, 75,000-square-foot tower. The $80 million addition, which will be attached to the emergency department, will occupy the plot of land where the old emergency department parking lot now sits. The first floor of the new Read More →

Read More →
Latest

Amgen cancer drug Kyprolis to get expedited review from FDA

By   /  Friday, September 18th, 2015  /  Central Coast Health Watch, Latest news, Tri-County Public Companies  /  Comments Off on Amgen cancer drug Kyprolis to get expedited review from FDA

An experimental multiple myeloma treatment using Amgen’s Kyprolis will get an expedited review from the U.S. Food and Drug Administration. The FDA said it will use an expedited review process to review a multiple-myeloma treatment using Kyprolis and the genric drug dexamethasone. On July 23, Amgen submitted additional data to the FDA which compared this Read More →

Read More →
Latest

Amgen buys biotech company, partners with another

By   /  Wednesday, September 16th, 2015  /  Central Coast Health Watch, Latest news, Technology, Top Stories, Tri-County Public Companies  /  Comments Off on Amgen buys biotech company, partners with another

Thousand Oaks-based biopharmaceutical giant Amgen bought a Netherlands-based company and partnered with a Monrovia-based company in an effort to fend off competitors. Amgen announced Sept. 16 that it will buy Dezima, a biotech company focused on developing new treatments for dyslipidemia, a disease where a person has an abnormal amount of lipids in their blood. Read More →

Read More →
Latest

Amgen shares drop as Novartis launches cheaper drug

By   /  Thursday, September 3rd, 2015  /  Central Coast Health Watch, East Ventura County, Latest news, Top Stories, Tri-County Public Companies  /  Comments Off on Amgen shares drop as Novartis launches cheaper drug

Amgen, the giant biotech company based in Thousand Oaks, saw its shares drop 2 percent to $149.23 on Sept. 3 after its rival Novartis launched a drug similar to Amgen’s that costs 15 percent less. Novartis’ Zarxio and Amgen’s Neupogen both help chemotherapy patients battle infections by increasing the production of white blood cells. The Read More →

Read More →
Latest

Westlake Village-based Kythera Biopharmaceuticals reports second quarter loss

By   /  Monday, August 10th, 2015  /  Central Coast Health Watch, Earnings, Latest news, Tri-County Public Companies  /  Comments Off on Westlake Village-based Kythera Biopharmaceuticals reports second quarter loss

Westlake Village-based Kythera Biopharmaceuticals missed analyst estimates when it released second quarter earnings on Aug. 6. Kythera lost $1.44 per share, missing analyst estimates of a loss of $1.10 per share. For the quarter, Kythera lost $37.2 million, compared to $19.5 million during the second quarter of 2014. On June 17, Allergan announced that it Read More →

Read More →